EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

How good is good enough? A simulation study of Adaptive HTA

Jamaica Roanne V Briones, Peter Baker, Wanrudee Isaranuwatchai, Alec Morton

Value in Health · 2026

DOI: 10.1016/j.jval.2026.01.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2026. Verfasst von Jamaica Roanne V Briones und 3 weiteren Autor:innen. Beteiligte Einrichtung: Saw Swee Hock School of Public Health, National University of Singapore, Singapore. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Computer Simulation, Reimbursement Mechanisms. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bill & Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study evaluated how uncertainty in adaptive health technology assessment (aHTA) affects reimbursement decisions and identified factors contributing to this uncertainty. METHODS: A simulation-based approach was used to generate a distribution of aHTA incremental cost-effectiveness ratios (ICERs). ICERs sampled from systematic reviews of 7 technologies were adjusted using (1) USD adjustment for currency and inflation and (2) technology price adjustment. Uncertainty in aHTA was quantified by estimating the probability of wrong reimbursement decisions using a willingness-to-pay (WTP)-threshold-based decision rule. This involved comparing decisions based on the simulated aHTA ICER with a decision based on a known ICER from Thailand, serving as the "true" reference ICER. Financial risk of wrong reimbursement decisions from the aHTA approach was also quantified. RESULTS: The probability of wrong decisions from aHTA decreased when aHTA ICERs were clearly above or below the WTP threshold. Low variability among published ICERs, particularly when studies shared a similar methodological framework, improved confidence in aHTA. Simple adjustments to ICERs, such as technology price adjustments, showed potential in reducing variability across studies. Technologies with modest disease burden and lower cost were associated with smaller financial risks, even under uncertain evidence. CONCLUSIONS: The aHTA approach is likely suitable under 3 conditions: (1) when the aHTA ICER is clearly positioned far from a country's WTP threshold, (2) when published ICERs exhibit low variability, and (3) when disease burden and financial risks are modest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technology Assessment, BiomedicalComputer SimulationReimbursement MechanismsCost-Benefit AnalysisCost-Effectiveness AnalysisHumansUncertaintyDecision MakingThailandDecision Support TechniquesModels, Economic

Stichwörter der Autor:innen

adaptive HTAhealth technology assessmentpriority settingrapid HTAsimulation

Autor:innen und Institutionen

  • Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
  • Center for Global Development, London, England, UK.
  • Health Intervention and Technology Assessment Program Foundation, Bangkok, Thailand.
  • Saw Swee Hock School of Public Health, National University of Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Strathclyde Business School, University of Strathclyde, Glasgow, Scotland, UK. Electroni…

Förderung

  • Bill & Melinda Gates Foundation

Zitieren

APA

Briones, J. R. V., Baker, P., Isaranuwatchai, W., & Morton, A. (2026). How good is good enough? A simulation study of Adaptive HTA. Value in Health. https://doi.org/10.1016/j.jval.2026.01.006

Vancouver

Briones JRV, Baker P, Isaranuwatchai W, Morton A. How good is good enough? A simulation study of Adaptive HTA. Value in Health. 2026. doi:10.1016/j.jval.2026.01.006

BibTeX
@article{Briones2026,
  author = {Briones, Jamaica Roanne V and Baker, Peter and Isaranuwatchai, Wanrudee and Morton, Alec},
  title = {How good is good enough? A simulation study of Adaptive HTA},
  journal = {Value in Health},
  year = {2026},
  doi = {10.1016/j.jval.2026.01.006}
}
Kostenlos starten →